GlassScriptPhysician profile
Ernesto Hayn
NPI 1912982679
$5,809.39
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $659 · 2020: $544 · 2021: $1,202 · 2022: $1,841 · 2023: $998 · 2024: $565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,563.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $2,364.90 | 2020-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Mentor Worldwide LLC | $1,133.90 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Mentor Memorygel Breast Implant |
| Sientra, INC. | $716.79 | 2020-2022 | |
| Musculoskeletal Transplant Foundation INC. | $337.35 | 2019-2023 | |
| Integra Lifesciences Corporation | $310.38 | 2020-2022 | |
| Smith+Nephew, INC. | $188.51 | 2019-2022 | |
| Davol INC. | $110.57 | 2020 | |
| Allergan, INC. | $85.14 | 2019-2022 | |
| Organogenesis INC. | $75.28 | 2020-2022 | |
| Abbvie INC. | $69.71 | 2023 | |
| Tei Biosciences INC | $65.96 | 2019 | |
| Dilon Technologies, INC. | $51.37 | 2024 | Hemoblast Bellows |
| Axogen | $49.31 | 2019 | |
| Galderma Laboratories, L.P. | $46.28 | 2019-2023 | |
| Coopersurgical, INC. | $43.45 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $41.05 | 2022-2023 | Seglentis |
| Ethicon US, LLC | $35.44 | 2021 | |
| Acera Surgical, INC. | $25.55 | 2021 | |
| Kci USA, INC. | $18.99 | 2023 | Activ.A.C., Prevena |
| Pacira Pharmaceuticals Incorporated | $17.22 | 2019 | |
| Boston Scientific Corporation | $15.59 | 2023 | |
| Kerecis Limited | $6.65 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ernesto Hayn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.